ISSN:

Journal Home

Journal Guideline

Synergy Q3 Unclaimed

Elsevier B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Synergy is a journal indexed in SJR in Cell Biology and Molecular Biology with an H index of 15. It has a price of 1620 €. It has an SJR impact factor of 0,354 and it has a best quartile of Q3. It has an SJR impact factor of 0,354.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q3) Pharmacology (medical) (Q3) Cell Biology (Q4) Molecular Biology (Q4)

Price

1620 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,354

SJR Impact factor

15

H Index

0

Total Docs (Last Year)

9

Total Docs (3 years)

0

Total Refs

24

Total Cites (3 years)

9

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

BMC Molecular and Cell Biology Q3
Purinergic Signalling Q3
Stem Cell Investigation Q3
Differentiation; Research in Biological Diversity Q3
Differentiation Q3

Compare this journals

Synergy Q3 Unclaimed

1620 €

NPD

0 €

Metrics

0,354

15

0

9

0

24

9

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of Synergy?